Tag Archives: ITHUF

Best Small Cap Stocks To Buy For 2019

Leave a reply

Small cap radio broadcasting stock Entercom Communications Corp (NYSE: ETM), a potential peer of Emmis Communications Corporation (NASDAQ: EMMS), Saga Communications (NYSEAMERICAN: SGA) and troubled Cumulus Media (NASDAQ: CMLS), is the tenth most shorted stock on the NYSE with short interest of 45.06% according to Highshortnterest.com.

Small cap Entercom Communications Corp is the fourth-largest radio broadcasting company in the U.S., reaching and engaging more than 40 million people a week through its portfolio of highly rated stations in top markets across the country. Entercom Communications Corp says its a “purpose-driven company, deeply committed to entertaining and informing its listeners with the best locally curated music, news, sports, and talk content, driven by compelling local personalities.” The Company delivers superior ROI by connecting its customers and audiences through its leading local brands and unparalleled local marketing solutions, which include over 4,000 events each year, and its SmartReach Digital product suite. 

Best Small Cap Stocks To Buy For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Keith Speights]

    What about Florida? If you want to stick with marijuana growers, one possibility is iAnthus Capital Holdings (NASDAQOTH:ITHUF). The company holds one of only 13 cannabis licenses in Florida and also has operations in three other states. Its stock ranked as the No. 2 best-performing marijuana stock in the first half of 2018.

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed this week:

    22nd Century Group Inc (NYSE: XXII): down 0.5 percent
    Aphria Inc (OTC: APHQF): down 3.6 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 0.8 percent
    Cannabis Sativa Inc (OTC: CBDS): down 7.2 percent
    CannTrust Holdings Inc (OTC: CNTTF): down 3.4 percent
    Canopy Growth Corp (NYSE: CGC): down 3.9 percent
    Cronos Group Inc. (NASDAQ: CRON): down 3.5 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 4.1 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 3.1 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 4.8 percent
    iAnthus Capital Holdings Inc (OTC: ITHUF): up 4.5
    MassRoots Inc (OTC: MSRT): down 4 percent
    MedReleaf Corp(OTC: MEDFF): down 1.8 percent
    Scotts Miracle-Gro Co (NYSE: SMG): down 0.3 percent
    THC Biomed Intl Ltd (OTC: THCBF): up 9.3 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): down 1.4 percent
    In Other News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey. You can answer following this link.

  • [By Sean Williams]

    There’s also the more than $600 million deal between iAnthus Capital Holdings (NASDAQOTH:ITHUF) and MPX Bioceutical, which recently closed. Following closure, iAnthus Capital now has a presence in 11 U.S. states, with 19 open dispensaries. However, the combined retail dispensary license count is 63, meaning iAnthus has a path to significant storefront growth, and a planned tripling in its cultivation capacity, too.

Best Small Cap Stocks To Buy For 2019: STAAR Surgical Company(STAA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) hit a new 52-week high and low during mid-day trading on Friday . The company traded as low as $28.55 and last traded at $28.42, with a volume of 6590 shares changing hands. The stock had previously closed at $27.80.

  • [By Max Byerly]

    Shares of STAAR Surgical (NASDAQ:STAA) have earned a consensus rating of “Buy” from the eight brokerages that are covering the firm, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation and two have given a strong buy recommendation to the company. The average 1 year price objective among brokerages that have covered the stock in the last year is $38.75.

  • [By Keith Speights]

    Shares of STAAR Surgical Company (NASDAQ:STAA) were up 21.5% as of 11:25 a.m. EDT on Thursday. The big jump occurred after the maker of implantable lenses announced its second-quarter earnings results on Wednesday evening.

Best Small Cap Stocks To Buy For 2019: State Auto Financial Corporation(STFC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    State Auto Financial (NASDAQ:STFC) was upgraded by equities researchers at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Friday.

  • [By Motley Fool Transcribers]

    State Auto Financial Corp  (NASDAQ:STFC)Q4 2018 Earnings Conference CallFeb. 14, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Max Byerly]

    Third Point Reinsurance (NASDAQ: STFC) and State Auto Financial (NASDAQ:STFC) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on State Auto Financial (STFC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Medical Stocks For 2019

Leave a reply

Senators Explore Bipartisan `Plan B’ to Troubled GOP Health Bill

5 Top States for Annuity Payment Growth

How the Survival of the Affordable Care Act Could Affect You

The new version of the Senate’s Affordable Care Act change bill could strip many federal rules from the off-exchange individual major medical market, and nudge the public health insurance system to focus on serving people with health problems.

The Senate Budget Committee posted a copy of the Better Care Reconciliation Act bill update today on its website. A copy of the bill is available here. 

Sen. Lisa Murkowski, R-Alaska (Photo: Murkowski)

Seema Verma asked for ideas about how to make things better. You replied.

You are signed up!

Your resource for news, research and analysis to help you deliver more effective outcomes to your clients. width:300px!important;max-height:36px; ThinkAdvisor TechCenter

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources How to thrive in a post-DOL rule world

Tools to help you survive in the post-DOL rule world.

Hot Medical Stocks For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Sean Williams]

    There’s also the more than $600 million deal between iAnthus Capital Holdings (NASDAQOTH:ITHUF) and MPX Bioceutical, which recently closed. Following closure, iAnthus Capital now has a presence in 11 U.S. states, with 19 open dispensaries. However, the combined retail dispensary license count is 63, meaning iAnthus has a path to significant storefront growth, and a planned tripling in its cultivation capacity, too.

  • [By Javier Hasse]

    Licensed cannabis production facilities owner and operator iAnthus Capital Holdings Inc (OTC: ITHUF) announced a $50 million investment from Gotham Green Partners. Management believes this is the largest investment to date by a single investor in a publicly traded U.S. cannabis operating company. iAnthus plans to allocate the proceeds of this financing to repay a $20 million one-year note and accrued interest to VCP Bridge LLC; continue to build out cultivation facilities and dispensaries in the New York and Florida markets; and, potentially, to expand activities. The remaining expenditures for completing iAnthus’ Massachusetts and Vermont operations will be funded with current cash on hand, management assured.

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

  • [By Keith Speights]

    What about Florida? If you want to stick with marijuana growers, one possibility is iAnthus Capital Holdings (NASDAQOTH:ITHUF). The company holds one of only 13 cannabis licenses in Florida and also has operations in three other states. Its stock ranked as the No. 2 best-performing marijuana stock in the first half of 2018.

Hot Medical Stocks For 2019: CVB Financial Corporation(CVBF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on CVB Financial (CVBF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    CVB Financial (NASDAQ:CVBF) was upgraded by equities research analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research note issued on Thursday.

  • [By Shane Hupp]

    Glen Harbor Capital Management LLC reduced its holdings in CVB Financial Co. (NASDAQ:CVBF) by 45.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,054 shares of the financial services provider’s stock after selling 17,754 shares during the period. Glen Harbor Capital Management LLC’s holdings in CVB Financial were worth $477,000 as of its most recent filing with the Securities and Exchange Commission.

Hot Medical Stocks For 2019: Alexandria Real Estate Equities, Inc.(ARE)

Advisors’ Opinion:

  • [By Logan Wallace]

    Alexandria Real Estate Equities (NYSE:ARE) issued an update on its FY19 earnings guidance on Monday morning. The company provided earnings per share guidance of $6.85-$7.05 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.94. Alexandria Real Estate Equities also updated its FY 2019 guidance to $6.85-7.05 EPS.

  • [By Stephan Byrd]

    Aecon Group Inc. (TSE:ARE) – Stock analysts at Desjardins cut their FY2018 earnings estimates for Aecon Group in a research note issued to investors on Thursday, May 24th. Desjardins analyst B. Poirier now forecasts that the company will post earnings of $0.96 per share for the year, down from their prior forecast of $1.14. Desjardins currently has a “Buy” rating on the stock.

  • [By Joseph Griffin]

    Alexandria Real Estate Equities Inc (NYSE:ARE) insider Dean A. Shigenaga sold 9,000 shares of the business’s stock in a transaction dated Monday, August 20th. The shares were sold at an average price of $129.59, for a total value of $1,166,310.00. Following the completion of the transaction, the insider now directly owns 148,645 shares of the company’s stock, valued at approximately $19,262,905.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

  • [By Todd Campbell]

    It’s not just tech companies that can trace their roots back to a garage. According to co-founder Joel Marcus, Alexandria Real Estate Equities (NYSE:ARE) — a real estate investment trust specializing in life sciences laboratory and office space — got its start in a garage, too. Since its founding in 1994, Alexandria Real Estate has grown into an $18 billion commercial real estate Goliath with $1.1 billion in annual revenue. Can this company’s success continue? I recently spoke with Marcus to learn more about the company and its opportunities.

  • [By Max Byerly]

    Bank of Nova Scotia trimmed its stake in shares of Alexandria Real Estate Equities Inc (NYSE:ARE) by 12.2% during the second quarter, HoldingsChannel reports. The institutional investor owned 11,358 shares of the real estate investment trust’s stock after selling 1,574 shares during the period. Bank of Nova Scotia’s holdings in Alexandria Real Estate Equities were worth $1,434,000 at the end of the most recent reporting period.

Best Casino Stocks To Own Right Now

Leave a reply

Patrons enjoying an evening outdoors at Bryant Park Grill & Café (Source: Company Website)

Business Summary

Ark Restaurants Corp. (NASDAQ:ARKR) owns and operates 21 restaurant/bars and 19 fast food concepts/catering operations with different trade names except for Gallagher’s and Rustic Inn, of which there are pairs of each. Notably, ARKR owns Bryant Park Grill & Café and the Clyde Frazier’s Wine and Dine in Manhattan (for basketball fans, yes that is the Walt Clyde Frazier, point-guard-turned-MSG-commentator who helped the Knicks capture the NBA championships in 1970 and 1973 – ARKR has had a partnership with Frazier to run the restaurant since March 2012). The company started in New York City but began expanding its restaurant/bar footprint into other states over the years with an affinity to “destination properties” over the years such as casinos (Foxwoods in Connecticut for example), water-view properties, and even historically relevant buildings such as Faneuil Hall in Boston. In fiscal 2016, the company generated revenues of $150.2 million, up from $145.9 million the previous year and currently trades at an $86 million market cap (roughly $25 per share).

Best Casino Stocks To Own Right Now: ONEOK Inc.(OKE)

Advisors’ Opinion:

  • [By Reuben Gregg Brewer]

    However, you could happily add ONEOK, Inc. (NYSE:OKE) without facing any of those issues, because this midstream company is structured as a regular corporation. Although ONEOK’s yield of 4.8% is a little lower than Enterprise’s, it shares a lot of the partnership’s most desirable traits.

  • [By Matthew DiLallo]

    Last year was an excellent one for ONEOK (NYSE:OKE). The pipeline giant was one of the best-performing energy stocks in the S&P 500, albeit in a down year for the market, thanks to a big uptick in earnings and cash flow through the third quarter. We’ll find out later this week if that trend continued during the fourth quarter, which is one of a few things investors should keep an eye on when the pipeline giant reports earnings.

  • [By Lee Jackson]

    The volatile price of natural gas over the past year has weighed some on this top energy company. ONEOK Inc. (NYSE: OKE) primarily engages in natural gas transportation, storage and natural gas and NGLs gathering, processing and fractionation in the Bakken, Mid-Continent and Permian. The company recently closed the roll-up of its underlying master limited partnership, ONEOK Partners.

  • [By Matthew DiLallo]

    ONEOK (NYSE:OKE) has made several shrewd moves over the past few years, which have positioned it to grow its high-yielding dividend at a high rate. One of the latest is its recent deal to buy out Martin Midstream Partners’ (NASDAQ:MMLP) 20% interest in the West Texas LPG pipeline system. With full control of that pipeline, the company can more aggressively pursue expansion opportunities, which recently led it to secure a second project on the system that positions it for even more growth in the future.

  • [By Shane Hupp]

    ONEOK (NYSE:OKE) – Analysts at US Capital Advisors raised their FY2018 EPS estimates for ONEOK in a research report issued to clients and investors on Monday, May 14th. US Capital Advisors analyst B. Followill now anticipates that the utilities provider will post earnings of $2.74 per share for the year, up from their previous forecast of $2.56. US Capital Advisors also issued estimates for ONEOK’s Q4 2018 earnings at $0.74 EPS and FY2019 earnings at $2.95 EPS.

Best Casino Stocks To Own Right Now: Sohu.com Inc.(SOHU)

Advisors’ Opinion:

  • [By Rick Munarriz]

    I’ve been covering Sohu.com (NASDAQ:SOHU) for awhile, so when the Chinese internet pioneer announced plans to spin off Sogou, I was more than a little interested. Sogou has been the main growth driver at Sohu for years. With Sohu’s online advertising business meandering and its internet gaming business proving volatile, search has been its crown jewel.

  • [By Rick Munarriz]

    The market isn’t warming up to Sohu.com’s (NASDAQ:SOHU) latest financial report. Its shares are hitting their lowest levels since the summer of 2007 after the Chinese online advertising, search, and gaming specialist posted disappointing first-quarter results on Wednesday morning. 

  • [By Rick Munarriz]

    Lumber Liquidators (NYSE:LL), Camping World Holdings (NYSE:CWH), and Sohu.com (NASDAQ:SOHU) have taken a beating this year. They’re among the biggest losers through the first three quarters of 2018. Let’s go over why I think they have a shot at bouncing back in the next three months.

  • [By Rick Munarriz]

    Sohu.com (NASDAQ:SOHU) is still struggling to fire on all cylinders, but investors nonetheless bid shares of the dot-com pioneer higher on Friday after it posted mixed fourth-quarter results. Revenue clocked in at $482.2 million for the final three months of 2018, a 5% decline from a year earlier, but a 5% sequential improvement. 

  • [By Anders Bylund]

    Sogou’s shares are prone to big swings for a couple of simple reasons.

    As a Chinese business, many American investors don’t feel connected to Sogou’s business and might not have access to some important sources of information about this company and its stock. Though Sogou has been around for nearly a decade now, it only entered the public markets in November of 2017. It’s a new ticker, untested on the market, and not always easily understood through year-over-year or longer-term analyses. At the IPO, Chinese internet giants Tencent (NASDAQOTH:TCEHY) and Sohu.com (NASDAQ:SOHU) combined for a total ownership of 82% of Sogu’s business. Those stakes later declined to 71%, but Sohu and Tencent remain Sogou’s largest shareholders, with 96% of the voting power in shareholder elections and votes. Regular investors hold a very small stake in Sogou, which tends to boost the stock’s volatility.

    Moreover, Chinese regulators launched an investigation of Sogou in June, forcing the company to shut down parts of its online advertising operations for 10 days in early July. The company is accused of showing video ads that insulted a national hero. That blackout will reduce Sogou’s third-quarter revenues by a significant but unannounced amount.

Best Casino Stocks To Own Right Now: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By ]

    Much of the focus of cannabis investors has been centered on Canada and California. This makes sense given that they are the two largest recreational (or soon to be) cannabis markets in the world. However, one publicly traded company with US-centric cannabis operations has taken a different approach. iAnthus Capital is listed in Canada on the CSE (OTCQB:ITHUF), but is headquartered in New York and incorporated in Delaware. Unlike other Canadian-listed cannabis companies, most of which are aiming to get in on the highly competitive green-rush in California and Canada, iAnthus has set its sights on becoming the dominant player on the U.S. East Coast.

  • [By Spencer Israel]

    The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy. The blue line represents a predictive moving average that shows what’s going to happen three days in advance, and the black line is a simple 10-day moving average. A crossover of the blue line over the black line indicates a bullish signal from the software, and vice versa for a bearish signal.

    iAthus Capital Holdings, Inc. (OTC: ITHUF)

    Up 94 percent YTD

  • [By Sean Williams]

    With this in mind, here are the pot stocks offering the highest revenue potential in fiscal 2019, listed in descending order:

    Aurora Cannabis (NYSE:ACB): $244.5 million The Green Organic Dutchman: $227.1 million Canopy Growth (NYSE:CGC): $190.4 million MedMen Enterprises: $188.9 million iAnthus Capital Holdings (NASDAQOTH:ITHUF): $181.4 million Village Farms International: $147.6 million GW Pharmaceuticals: $123 million KushCo Holdings (NASDAQOTH:KSHB): $117.9 million Aphria (NYSE:APHA): $107.4 million CannTrust Holdings: $105.5 million

    Image source: Getty Images.

Top Growth Stocks To Buy For 2019

Leave a reply

The stock market mostly bounced higher on Wednesday following losses earlier in the week, with the Nasdaq Composite vaulting to new highs on strength in technology stocks. investors have gravitated toward the highest-growth areas of the market, leaving slower-growing value stocks behind in many cases. Good news from several individual companies also helped lift their share prices. Winnebago Industries (NYSE:WGO), Synaptics (NASDAQ:SYNA), and Tesaro (NASDAQ:TSRO) were among the best performers on the day. Here’s why they did so well.

Winnebago hits the gas

Shares of Winnebago Industries jumped 15% after the recreational vehicle specialist announced its fiscal third-quarter financial results. Winnebago said that sales climbed to record levels during the quarter, helping earnings jump by two-thirds from the year-ago period. As CEO Michael Happe noted, “New product performance, our evolving portfolio mix, and agility in managing cost pressures all contributed nicely to our third quarter results.” The only potential headwind down the road could come from inflationary pressure in obtaining the raw materials necessary to manufacture its RVs, but for the most part, Winnebago is confident that it can use cost-cutting measures elsewhere to insulate its bottom line from any potential negative impact.

Top Growth Stocks To Buy For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Spencer Israel]

    The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy. The blue line represents a predictive moving average that shows what’s going to happen three days in advance, and the black line is a simple 10-day moving average. A crossover of the blue line over the black line indicates a bullish signal from the software, and vice versa for a bearish signal.

    iAthus Capital Holdings, Inc. (OTC: ITHUF)

    Up 94 percent YTD

  • [By Sean Williams]

    With this in mind, here are the pot stocks offering the highest revenue potential in fiscal 2019, listed in descending order:

    Aurora Cannabis (NYSE:ACB): $244.5 million The Green Organic Dutchman: $227.1 million Canopy Growth (NYSE:CGC): $190.4 million MedMen Enterprises: $188.9 million iAnthus Capital Holdings (NASDAQOTH:ITHUF): $181.4 million Village Farms International: $147.6 million GW Pharmaceuticals: $123 million KushCo Holdings (NASDAQOTH:KSHB): $117.9 million Aphria (NYSE:APHA): $107.4 million CannTrust Holdings: $105.5 million

    Image source: Getty Images.

  • [By Javier Hasse]

    Licensed cannabis production facilities owner and operator iAnthus Capital Holdings Inc (OTC: ITHUF) announced a $50 million investment from Gotham Green Partners. Management believes this is the largest investment to date by a single investor in a publicly traded U.S. cannabis operating company. iAnthus plans to allocate the proceeds of this financing to repay a $20 million one-year note and accrued interest to VCP Bridge LLC; continue to build out cultivation facilities and dispensaries in the New York and Florida markets; and, potentially, to expand activities. The remaining expenditures for completing iAnthus’ Massachusetts and Vermont operations will be funded with current cash on hand, management assured.

  • [By Javier Hasse]

    Here are some of the top marijuana stocks in U.S. exchanges and how the performed over the last five trading days (percentages reflect approximate equity moves as of the time of the writing of this article.

    22nd Century Group Inc (NYSE: XXII): up 4.5 percent
    Aphria Inc (OTC: APHQF): down 1.4 percent
    Aurora Cannabis Inc (OTC: ACBFF): up 0.6 percent
    Cannabis Sativa Inc (OTC: CBDS): down 6.3 percent
    CannTrust Holdings Inc (OTC: CNTTF): down 3.3 percent
    Canopy Growth Corp (NYSE: CGC): up 1.8 percent
    Cronos Group Inc. (NASDAQ: CRON): up 9.3 percent
    GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH): up 2.2 percent
    Hiku Brands Company Ltd(OTC: DJACF): down 15.5 percent
    India Globalization Capital, Inc. (NYSE: IGC): down 1.9 percent
    iAnthus Capital Holdings Inc (OTC: ITHUF): up 4.6 percent
    MassRoots Inc (OTC: MSRT): down 0.2 percent
    MedReleaf Corp(OTC: MEDFF): up 1.1 percent
    Scotts Miracle-Gro Co (NYSE: SMG): down 3.6 percent
    THC Biomed Intl Ltd (OTC: THCBF): down 5.5 percent
    Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE): up 7.3 percent
    In Other News

    A consortium of cannabis-related media professionals are conducting a Cannabis Media Survey. You can answer following this link.

  • [By Sean Williams]

    For instance, iAnthus Capital Holding (NASDAQOTH:ITHUF) recently completed the largest U.S. deal to date by purchasing MPX Bioceutical for around $600 million. (This deal will be eclipsed by MedMen’s purchase of PharmaCann, once that deal closes.) Though it’s unclear what sort of premium iAnthus paid for MPX Bioceutical as of yet, a quick glance at iAnthus Capital’s balance sheet shows that 55% of its total assets are currently tied up in goodwill. Since the dispensary space will presumably have plenty of competition, it’s unclear if iAnthus (or other acquisition-hungry dispensaries) will be able to recoup the premium it’s paid to buy other businesses. This leaves the door open for hefty future writedowns.

Top Growth Stocks To Buy For 2019: Clearside BioMedical, Inc. (CLSD)

Advisors’ Opinion:

  • [By Brian Orelli]

    Shares of Clearside Biomedical (NASDAQ:CLSD) are down 26% at 12:47 p.m. EDT after the company announced what it called “positive topline results” from the phase 2 Tybee trial testing its steroid treatment, CLS-TA, in patients with an eye disease called diabetic macular edema.

  • [By Shane Hupp]

    MetLife Investment Advisors LLC purchased a new position in shares of Clearside Biomedical Inc (NASDAQ:CLSD) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 10,859 shares of the company’s stock, valued at approximately $117,000.

  • [By Chris Lange]

    Clearside Biomedical Inc. (NASDAQ: CLSD) shares dropped early on Thursday after the company released data from its midstage clinical trial for diabetic macular edema (DME). Specifically, this data came from the Phase 2 clinical trial (TYBEE) evaluating suprachoroidal CLS-TA used with intravitreally administered Eylea (aflibercept).

  • [By Ethan Ryder]

    Here are some of the news articles that may have effected Accern Sentiment Analysis’s analysis:

    Get Catabasis Pharmaceuticals alerts:

    Analysts Offer Insights on Healthcare Companies: Clearside Biomedical (NASDAQ: CLSD) and Bluebird Bio (NASDAQ … (analystratings.com) Catabasis launches public equity offering (seekingalpha.com) Friedreich Ataxia Market Pipeline Therapeutics 2018 Top Key Players, Drug Profile and Product Description (thecleantechnology.com) Cellectis SA Receives a Buy from Oppenheimer (analystratings.com) Global Type I Hyperlipoproteinemia Drug Market 2018- Catabasis Pharmaceuticals, Inc., uniQure NV , Isis … (afinancialanalysis.com)

    Shares of Catabasis Pharmaceuticals traded down $0.28, reaching $1.06, on Monday, Marketbeat reports. The company’s stock had a trading volume of 2,344,684 shares, compared to its average volume of 645,019. The firm has a market cap of $38.91 million, a price-to-earnings ratio of -0.84 and a beta of 0.74. Catabasis Pharmaceuticals has a 52 week low of $1.00 and a 52 week high of $3.78.

  • [By Ethan Ryder]

    Shares of Clearside Biomedical Inc (NASDAQ:CLSD) have earned a consensus recommendation of “Buy” from the ten brokerages that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have given a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $22.40.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Clearside Biomedical, Inc. (NASDAQ: CLSD) shares fell 17.8 percent to $11.95 in pre-market trading. Clearside Biomedical disclosed that its Phase 2 trial of CLS-TA met primary and secondary endpoints met in 6-month trial.
    CRISPR Therapeutics AG (NASDAQ: CRSP) fell 15.8 percent to $62.00 in pre-market trading after the company disclosed that the FDA has placed a clinical hold on IND for CTX001 sickle cell disease treatment.
    Sears Holdings Corporation (NASDAQ: SHLD) fell 10 percent to $2.89 in pre-market trading after the company posted a loss for the first quarter and announced plans to close 72 non-profitable stores.
    Urban One, Inc. (NASDAQ: UONE) fell 9 percent to $3.01 in pre-market trading after rising 78.38 percent on Wednesday.
    Dollar Tree, Inc. (NASDAQ: DLTR) shares fell 8.6 percent to $88.05 in pre-market trading after the company reported weaker-than-expected earnings for its first quarter and lowered its FY2018 earnings guidance.
    Ciena Corporation (NYSE: CIEN) fell 8.5 percent to $22.02 in the pre-market trading session after the company posted downbeat Q1 earnings and announced plans to buy Packet Design.
    Dollar General Corporation (NYSE: DG) shares fell 6.6 percent to $90.11 in pre-market trading after reporting weaker-than-expected results for its first quarter.
    Vericel Corp (NASDAQ: VCEL) shares fell 6.5 percent to $13.05 in pre-market trading following announcement of 3.75 million share common stock offering.
    Box, Inc. (NYSE: BOX) fell 5.7 percent to $26.19 in pre-market trading. Box reported upbeat results for its first quarter. The company forecast Q2 revenue of $146 million to $147 million.
    Co-Diagnostics, Inc. (NASDAQ: CODX) fell 5.7 percent to $3.15 in pre-market trading after declining 5.65 percent on Wednesday.
    Cherry Hill Mortgage Investment Corporation (NYSE: CHMI) shares fell 5.2 percent to $18.21 in pre-market trading after reporting a 2

Top Growth Stocks To Buy For 2019: E-House(China)

Advisors’ Opinion:

  • [By ]

    The world’s largest operating utility-scale solar projects are concentrated in China and India, according to IEEFA. Based on company and press reports, as well as its own estimates, those include:

    RankingProject NameSize MWCountryProponent 1Tengger Desert Solar Park1,547ChinaChina National Grid Zhongwei Power Supply Co2Kurnool Ultra Mega Solar Park1,000IndiaAndhra Pradesh Solar Power Corporation Pvt Ltd3Datong Solar Power Top Runner Base1,000ChinaMultiple4Yanchi Ningxia Solar Park1,000ChinaHuawei Technologies Co5Longyangxia Dam Solar Park850ChinaState Power Investment Corporation (China)6Adani Kamuthi Solar Plant648IndiaAdani Green7Solar Star579U.S.BHE Renewables8Topaz Solar Farm550U.S.First Solar9Desert Sunlight Solar Farm550U.S.NextEra Energy, GE Energy Financial & Sumitomo10Nova Olinda Solar Farm292BrazilEnel Green Power

    China added 53 gigawatts of the 98 gigawatts of new solar capacity built last year, a 31 percent increase from the total 2017, IEEFA said, citing Bloomberg New Energy Finance data. Meanwhile, the per unit cost of electricity over the life of a generating asset fell 15 percent year-on-year to $86 a megawatt hour.

Best Undervalued Stocks To Own For 2019

Leave a reply

Related GWPH Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Marijuana Stocks Go On Reversal Mode After 8 Weeks Of Gains: Cannabis Index Down From 52-Week High GW Pharma Oncology Is Potential Underrated (Seeking Alpha)
Related ZYNE Up In Smoke? DoJ Will 'Take Action' Against States That Have Legalized Marijuana Benzinga's Top Upgrades, Downgrades For February 24, 2017 Zynerba Pharmaceuticals Undervalued Compared To GW Pharmaceuticals (Seeking Alpha)

Top cannabis stocks took a hit Friday, after White House Press Secretary Sean Spicer suggested the federal government would enforce federal law in states where recreational weed has been legalized, even in spite of the Cole Memo.

Best Undervalued Stocks To Own For 2019: Chatham Lodging Trust (REIT)(CLDT)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Chatham Lodging Trust (CLDT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Teachers Insurance & Annuity Association of America raised its holdings in shares of Chatham Lodging (NYSE:CLDT) by 19.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 59,609 shares of the real estate investment trust’s stock after purchasing an additional 9,743 shares during the quarter. Teachers Insurance & Annuity Association of America owned 0.13% of Chatham Lodging worth $1,142,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    ValuEngine upgraded shares of Chatham Lodging Trust (NYSE:CLDT) from a sell rating to a hold rating in a research note released on Tuesday.

    Several other research firms have also recently weighed in on CLDT. Zacks Investment Research cut Chatham Lodging Trust from a hold rating to a sell rating in a research report on Friday, August 3rd. B. Riley increased their price objective on Chatham Lodging Trust from $20.00 to $21.00 and gave the stock a neutral rating in a research report on Thursday, August 2nd. TheStreet upgraded Chatham Lodging Trust from a c+ rating to a b- rating in a research report on Thursday, July 12th. Finally, Stifel Nicolaus reiterated a hold rating and set a $20.00 price objective on shares of Chatham Lodging Trust in a research report on Wednesday, August 1st. One analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. The stock has an average rating of Hold and an average price target of $21.20.

  • [By Shane Hupp]

    Chatham Lodging (NYSE:CLDT) announced a monthly dividend on Thursday, May 10th, Zacks reports. Shareholders of record on Thursday, May 31st will be paid a dividend of 0.11 per share by the real estate investment trust on Friday, June 29th. This represents a $1.32 annualized dividend and a yield of 6.38%. The ex-dividend date of this dividend is Wednesday, May 30th.

Best Undervalued Stocks To Own For 2019: TrovaGene, Inc.(TROV)

Advisors’ Opinion:

  • [By Paul Ausick]

    TrovaGene Inc. (NASDAQ: TROV) fell more than 55% Friday to post a new 52-week low of $0.79 after closing at $1.77 on Thursday. The 52-week high is $19.56. Volume of around 11 million was nearly five times the daily average of about 230,000. The company announced a public offering of $18 million in stock and warrants priced at $1.00 for the unit.

  • [By Stephan Byrd]

    TrovaGene Inc (NASDAQ:TROV) shares saw strong trading volume on Thursday . 1,477,200 shares were traded during trading, an increase of 185% from the previous session’s volume of 517,912 shares.The stock last traded at $0.83 and had previously closed at $0.81.

  • [By Logan Wallace]

    Media stories about TrovaGene (NASDAQ:TROV) have trended somewhat positive this week, Accern reports. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. TrovaGene earned a media sentiment score of 0.14 on Accern’s scale. Accern also gave news coverage about the medical research company an impact score of 45.974011377318 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

  • [By Logan Wallace]

    TrovaGene Inc (NASDAQ:TROV) has been assigned a consensus rating of “Hold” from the six research firms that are currently covering the stock, Marketbeat reports. Four investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $7.00.

Best Undervalued Stocks To Own For 2019: Rocky Mountain Chocolate Factory Inc.(RMCF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

  • [By Ethan Ryder]

    Rocky Mountain Chocolate Factory (NASDAQ: RMCF) and Tootsie Roll Industries (NYSE:TR) are both small-cap retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, dividends and analyst recommendations.

Best Undervalued Stocks To Own For 2019: iAnthus Capital Holdings, Inc. (ITHUF)

Advisors’ Opinion:

  • [By Keith Speights]

    Marijuana grower

    Canopy Growth Corporation (NYSE:CGC) $5.8 billion
      Aurora Cannabis (NASDAQOTH: ACBFF) $2.9 billion
      Tilray (NASDAQ: TLRY) $2.3 billion
      Aphria (NASDAQOTH: APHQF) $1.9 billion
      MedMen Enterprises (NASDAQOTH: MMNFF) $1.3 billion
      Cronos Group (NASDAQ: CRON) $1 billion
      The Green Organic Dutchman (NASDAQOTH: TGODF) $1 billion
      The Hydropothecary (NASDAQOTH: HYYDF) $728 million
      CannTrust Holdings (NASDAQOTH: CNTTF) $513 million
      Organigram Holdings (NASDAQOTH: OGRMF) $509 million
      Marimed (NASDAQOTH: MRMD) $472 million
      TerrAscend (NASDAQOTH: TRSSF) $398 million
      Auxly Cannabis (NASDAQOTH: CBWTF) $368 million
      iAnthus Capital Holdings (NASDAQOTH: ITHUF) $367 million
      Medical Marijuana (NASDAQOTH: MJNA) $330 million
      CV Sciences (NASDAQOTH: CVSI) $299 million
      Emerald Health Therapeutics (NASDAQOTH: EMHTF) $287 million
      Supreme Cannabis (NASDAQOTH: SPRWF) $277 million
      Smart Cannabis (NASDAQOTH: SCNA) $276 million
      MPX Bioceutical (NASDAQOTH: MPXEF) $234 million
      AusCann Group Holdings (NASDAQOTH: ACNNF) $223 million
      Liberty Health Sciences (NASDAQOTH: LHSIF) $213 million

    Biotech

  • [By Sean Williams]

    This past week, the largest marijuana deal to date in the U.S. closed, with iAnthus Capital Holdings (NASDAQOTH:ITHUF) ponying up north of $600 million for MPX Bioceutical. Following closure of the deal, iAnthus now has 19 open locations spanning 11 states (it only had a presence in six states prior to the deal), but has retail licenses in place to open as many as 63 retail locations. What’s more, the combined company now has 210,000 square feet of aggregate grow space, but is targeting a near-tripling in this amount to 600,000 square feet, spread across the states it conducts business. 

  • [By Sean Williams]

    For instance, iAnthus Capital Holding (NASDAQOTH:ITHUF) recently completed the largest U.S. deal to date by purchasing MPX Bioceutical for around $600 million. (This deal will be eclipsed by MedMen’s purchase of PharmaCann, once that deal closes.) Though it’s unclear what sort of premium iAnthus paid for MPX Bioceutical as of yet, a quick glance at iAnthus Capital’s balance sheet shows that 55% of its total assets are currently tied up in goodwill. Since the dispensary space will presumably have plenty of competition, it’s unclear if iAnthus (or other acquisition-hungry dispensaries) will be able to recoup the premium it’s paid to buy other businesses. This leaves the door open for hefty future writedowns.

  • [By ]

    Much of the focus of cannabis investors has been centered on Canada and California. This makes sense given that they are the two largest recreational (or soon to be) cannabis markets in the world. However, one publicly traded company with US-centric cannabis operations has taken a different approach. iAnthus Capital is listed in Canada on the CSE (OTCQB:ITHUF), but is headquartered in New York and incorporated in Delaware. Unlike other Canadian-listed cannabis companies, most of which are aiming to get in on the highly competitive green-rush in California and Canada, iAnthus has set its sights on becoming the dominant player on the U.S. East Coast.

  • [By Sean Williams]

    It’s not even just a Canadian problem. iAnthus Capital Holdings (NASDAQOTH:ITHUF), a vertically integrated cannabis dispensary with a focus on the U.S. market, recently closed on its purchase of MPX Bioceutical. This roughly $600 million deal increases the number of states iAnthus has access to from six to 11, and lifts its retail license count to 63. But take a gander at its most recent quarterly filing and you’ll see that CA$7.2 million in goodwill has not so magically transformed into CA$75.9 million in goodwill over a nine-month period, through Sept. 30, 2018. This represents 55% of the company’s total assets.

  • [By Spencer Israel]

    The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy. The blue line represents a predictive moving average that shows what’s going to happen three days in advance, and the black line is a simple 10-day moving average. A crossover of the blue line over the black line indicates a bullish signal from the software, and vice versa for a bearish signal.

    iAthus Capital Holdings, Inc. (OTC: ITHUF)

    Up 94 percent YTD

Best Undervalued Stocks To Own For 2019: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Max Byerly]

    Antares Pharma (NASDAQ:ATRS) was downgraded by equities research analysts at BidaskClub from a “buy” rating to a “hold” rating in a report issued on Friday.

  • [By Ethan Ryder]

    Antares Pharma (NASDAQ:ATRS) was upgraded by investment analysts at BidaskClub from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

  • [By Joseph Griffin]

    News articles about Antares Pharma (NASDAQ:ATRS) have trended somewhat positive on Sunday, according to Accern Sentiment. The research group scores the sentiment of media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Antares Pharma earned a news impact score of 0.18 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 45.2112654396991 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Motley Fool Transcribers]

    Antares Pharma Inc  (NASDAQ:ATRS)Q4 2018 Earnings Conference CallFeb. 28, 2019, 8:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator